FDA Panel Meeting Scheduled to Discuss Rx-to-OTC Switch of Oral Contraceptive Opill
Opill contains 0.075 mg of norgestrel, a single active steroid ingredient.
Contraception
Rx-to-OTC Switch Application Submitted for Oral Contraceptive Opill
If approved, Opill would be the first OTC oral contraceptive pill available without a prescription.
Some Pharmacies Limiting Morning-After Pill Sales to Avoid Potential Shortage
Temporary purchase limits aim to ensure ‘equitable access and consistent supply on store shelves’.
At-Home Test Helps With Birth Control Selection by Identifying Risk for Side Effects
Through hormone measurements and genetic analysis, the test can identify whether an individual is at increased risk for certain birth control side effects.
Ob/Gyn Update: Lack of Postpartum Contraceptive Use, Pelvic Pain Guidelines, and Infection Risk With Alternative Birth Practices
Recent OB/Gyn updates include underuse of contraceptives after giving birth, new guidelines on postpartum pelvic girdle pain, and infection risk with alternative birth practices.
Oral Contraceptive With Novel Estrogen Under FDA Review
The novel combined oral contraceptive pill includes estetrol 15mg (E4) and drospirenone 3mg (DRSP).
Oral Contraceptives Lower Ovarian Cancer Risk in BRCA Carriers
Findings seen in BRCA1 and BRCA2 mutation carriers; reduction greater with longer duration of use in BRCA1 carriers
Hormonal Contraception, Copper IUD Use Associated With Lower Risk for Ectopic Pregnancy
In a secondary analysis of the CHOICE Project, researchers concluded that contraception use is linked to a reduced risk for ectopic pregnancy.
Oral Contraceptives Protect Against Ovarian, Endometrial Cancer
Oral contraceptives have a lasting protective effect against ovarian and endometrial cancer, according to a new study.
Hormonal Contraceptives Linked to Decline in Asthma Exacerbation
Use of any and combined hormonal contraceptives is associated with a reduction in the risk for severe asthma exacerbation.
- Loading...
Loading...
Next post in Asthma Information Center
Loading... 
Loading...